Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | YX-02-030 |
Synonyms | |
Therapy Description |
YX-02-030 is a proteolysis-targeted chimera (PROTAC) that binds to MDM2 and targets it for degradation, potentially leading to tumor cell death (PMID: 36734633). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
YX-02-030 | YX-02030|YX 02030|YX 02 030 | MDM2 Inhibitor 23 | YX-02-030 is a proteolysis-targeted chimera (PROTAC) that binds to MDM2 and targets it for degradation, potentially leading to tumor cell death (PMID: 36734633). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|